Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01575028 · ClinicalTrials.gov registry record · Phase 2

Transversus Abdominis Plane (TAP) Versus Local Anesthetic for Lap Appendectomies

A Phase 2 study, sponsored by Nationwide Children's Hospital.

Terminated
Registry status
Phase 2
Development phase
3
Enrollment target

NCT01575028: Clinical Trial Phase 2 study, sponsored by Nationwide Children's Hospital.

NCT01575028 is a Phase 2 study that was terminated before completion, run by Nationwide Children's Hospital. The registered enrollment target is 3 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01575028, a Phase 2 study, was terminated before completion, sponsored by Nationwide Children's Hospital.

TERMINATED
Registry status
Phase 2
Development phase
3 participants
Enrollment target

Study Summary

This study is a prospective, double-blinded, randomized comparison of 2 patient cohorts. One group of patients will receive a transversus abdominis plane (TAP) block. The second group will receive local anesthetic infiltration injected at the surgical site by the surgeon at the end of surgery for a laparoscopic appendectomy. The purpose of this study is to prospectively compare post-operative pain relief in pediatric patients undergoing laparoscopic appendectomy who have received either a transversus abdominis plane (TAP) block or local anesthetic infiltration by the surgeon for analgesia to compare the most appropriate delivery of effective analgesia. In an effort to improve postoperative analgesia while limiting opioid-related adverse effects, there continues to be an increased use of multimodal techniques in infants and children.

Primary Outcome

Prospectively compare post-operative pain relief in pediatric patients undergoing laparoscopic appendectomy who have received either a transversus abdominis plane (TAP) block or local anesthetic infiltration by the surgeon for analgesia.

Interventions

  • DRUG Bupivacaine
  • DRUG Ropivacaine

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2012-10
Est. Completion 2014-07
Phase Phase 2
Nationwide Children's Hospital

188 total trials

Why NCT01575028 stopped before completion

NCT01575028 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.

NCT01575028 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01575028 about?

NCT01575028 is a clinical study titled "Transversus Abdominis Plane (TAP) Versus Local Anesthetic for Lap Appendectomies". This study is a prospective, double-blinded, randomized comparison of 2 patient cohorts. One group of patients will receive a transversus abdominis plane (TAP) block. The second group will receive local anesthetic infiltration injected at the surgical site by the surgeon at the end of surgery for a ...

What is the current status of trial NCT01575028?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2012-10. Estimated completion is 2014-07.

What interventions are being tested in trial NCT01575028?

The interventions under investigation include: Bupivacaine (DRUG), Ropivacaine (DRUG).

Who is sponsoring clinical trial NCT01575028?

This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01575028's enrollment target sits among peer trials

3 2001st of 2000 the lowest of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01575028, the US trial registry maintained by the National Library of Medicine. NCT01575028 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.